Ivayla Ivanova

Ivayla Ivanova

Auto-generated profile, based on publicly available information

Ivayla Ivanova

Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK 1

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Molecular Cell
Verified
Journal Article
Open access
IIIvayla Ivanova
Ivayla Ivanova
CMChristian Much
Christian Much
MGMonica Di Giacomo
Monica Di Giacomo
CAChiara Azzi
Chiara Azzi
MMMarcos Morgan
Marcos Morgan
DODónal O’cArroll
Dónal O’cArroll
YTHDF2 binds and destabilizes N6-methyladenosine (m6A)-modified mRNA. The extent to which this branch of m6A RNA-regulatory pathway functions in vivo and contributes to mammalian development remains unknown. Here we find that YTHDF2 deficiency is partially permissive in mice and results in female-specific infertility. Using conditional mutagenesis, we demonstrate that YTHDF2 is autonomously required within the germline to produce MII oocytes that are competent to sustain early zygotic development. Oocyte maturation is associated with a wave of maternal RNA degradation, and the resulting relative changes to the MII transcriptome are integral to oocyte quality. The loss of YTHDF2 results in the failure to regulate transcript dosage of a cohort of genes during oocyte maturation, with enrichment observed for the YTHDF2-binding consensus and evidence of m6A in these upregulated genes. In summary, the m6A-reader YTHDF2 is an intrinsic determinant of mammalian oocyte competence and early zygotic development.

6 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CMChristopher Mapperley
Christopher Mapperley
LLLouie N. van de Lagemaat
Louie N. van de Lagemaat
HLHannah Lawson
Hannah Lawson
ATAndrea Tavosanis
Andrea Tavosanis
JPJasmin Paris
Jasmin Paris
KKKamil R. Kranc
Kamil R. Kranc
The mRNA N6-methyladenosine (m6A) modification has emerged as an essential regulator of normal and malignant hematopoiesis. Inactivation of the m6A mRNA reader YTHDF2, which recognizes m6A-modified transcripts to promote m6A-mRNA degradation, results in hematopoietic stem cell (HSC) expansion and compromises acute myeloid leukemia. Here we investigate the long-term impact of YTHDF2 deletion on HSC maintenance and multilineage hematopoiesis. We demonstrate that Ythdf2-deficient HSCs from young mice fail upon serial transplantation, display increased abundance of multiple m6A-modified inflammation-related transcripts, and chronically activate proinflammatory pathways. Consistent with the detrimental consequences of chronic activation of inflammatory pathways in HSCs, hematopoiesis-specific Ythdf2 deficiency results in a progressive myeloid bias, loss of lymphoid potential, HSC expansion, and failure of aged Ythdf2-deficient HSCs to reconstitute multilineage hematopoiesis. Experimentally induced inflammation increases YTHDF2 expression, and YTHDF2 is required to protect HSCs from this insult. Thus, our study positions YTHDF2 as a repressor of inflammatory pathways in HSCs and highlights the significance of m6A in long-term HSC maintenance.

23 January 2013 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
VHVeronica Höiom
Veronica Höiom
DEDaniel Edsgärd
Daniel Edsgärd
HHHildur Helgadottir
Hildur Helgadottir
HEHanna Eriksson
Hanna Eriksson
CACharlotta All‐Ericsson
Charlotta All‐Ericsson
JHJohan Hansson
Johan Hansson

30 April 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
LVLina Vasiliauskaitė
Lina Vasiliauskaitė
RBRebecca Berrens
Rebecca Berrens
IIIvayla Ivanova
Ivayla Ivanova
CCClaudia Carrieri
Claudia Carrieri
WRWolf Reik
Wolf Reik
DODónal O’cArroll
Dónal O’cArroll